Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Articles published by Bayer

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stem and Root and Nutrileads Announce Launch of Daily Immunity for Optimized Immune Function Powered by BeniCaros for Ground Breaking Immunity Support

March 15, 2022

From Bayer

Via Business Wire

Positive Results from Phase III Investigational Trial Shows NUBEQA® (darolutamide) Plus Androgen Deprivation Therapy (ADT) and Docetaxel Significantly Increases Overall Survival (OS) in Patients with mHSPC

February 17, 2022

From Bayer

Via Business Wire

Bayer Highlights Advancements of Agriculture Industry’s Most Prolific R&D Pipeline

February 16, 2022

From Bayer

Via Business Wire

Bayer Receives FDA Fast Track Designation for asundexian Stroke Program

February 10, 2022

From Bayer

Via Business Wire

Bayer Earns Top Score in 2022 Corporate Equality Index for Fifth Consecutive Year

January 27, 2022

From Bayer

Via Business Wire

Bayer to Launch Project Carbonview, an Industry-First Digital Carbon Footprint Measurement Solution for Agriculture

December 08, 2021

From Bayer

Via Business Wire

Phase III Investigational Trial of NUBEQA® (darolutamide) in Combination with Docetaxel and Androgen Deprivation Therapy (ADT) Meets Primary Endpoint of Significantly Increasing Overall Survival (OS) in Patients with mHSPC

December 03, 2021

From Bayer

Via Business Wire

Bayer Invests €100 million in Sustainable Health Products to Advance Company’s 2030 Sustainability Commitments

December 01, 2021

From Bayer

Via Business Wire

Bayer Wins U.S. Chamber of Commerce Foundation’s Annual Citizens Award

November 18, 2021

From Bayer

Via Business Wire

Bayer Presented New Analyses Investigating KERENDIA® (finerenone) on Cardiovascular Outcomes in Patients With Chronic Kidney Disease Associated With Type 2 Diabetes

November 18, 2021

From Bayer

Via Business Wire

Bayer, Microsoft Enter Into Strategic Partnership to Optimize and Advance Digital Capabilities for Food, Feed, Fuel, Fiber Value Chain

November 17, 2021

From Bayer

Via Business Wire

Bayer Focuses on Farmers and Drives Innovation into 2022

November 11, 2021

From Bayer

Via Business Wire

Effective January 1, 2022: Rodrigo Santos Named Member of the Board of Management, Bayer AG, and President of the Crop Science Division

November 09, 2021

From Bayer

Via Business Wire

Bayer Presents New Subgroup Analysis of Prespecified Pooled Analysis of Phase III Studies for KERENDIA® (finerenone) for Chronic Kidney Disease Associated With Type 2 Diabetes With or Without SGLT2i Use at Baseline

November 08, 2021

From Bayer

Via Business Wire

Bayer Consumer Health Media Team Named AdExchanger Winner for Best In-House Media Operations

November 03, 2021

From Bayer

Via Business Wire

Bayer and CHS Collaborate to Bring Carbon Program Access to More Farmers

November 02, 2021

From Bayer

Via Business Wire

Bayer to present new analyses adding to the depth of knowledge on the cardiovascular and renal outcomes of KERENDIA® (finerenone)

October 27, 2021

From Bayer

Via Business Wire

During Breast Cancer Awareness Month, Bayer Shines a Light on the Impact of Breast Density on Breast Cancer Risk

October 25, 2021

From Bayer

Via Business Wire

Bayer fuels leading market positions in Crop Science through delivery of unmatched innovation

October 19, 2021

From Bayer

Via Business Wire

Bayer Appoints New General Managers for Nutritionals and Digestive Health Businesses

October 05, 2021

From Bayer

Via Business Wire

Updated Vitrakvi® (larotrectinib) Sub-Analysis at ATA 2021 Supports Efficacy and Safety in Adult and Pediatric TRK Fusion Thyroid Cancer Patients

October 04, 2021

From Bayer

Via Business Wire

Bayer Issues Voluntary Recall of Specific Lotrimin® and Tinactin® Spray Products Due to the Presence of Benzene

October 01, 2021

From Bayer

Via Business Wire

Midol® by Bayer Receives Honorable Mention in Fast Company’s 2021 Innovation by Design Awards

September 28, 2021

From Bayer

Via Business Wire

Bayer Hires Nicole Hayes as Director of U.S. External Communications

September 28, 2021

From Bayer

Via Business Wire

On the 15th Anniversary of World Contraception Day Bayer Releases Survey Results that Highlight the Role of Contraceptives in Women’s Lives

September 27, 2021

From Bayer

Via Business Wire

Bayer Extends Clinical Development Program for KERENDIA® (finerenone) With Phase III Study to Investigate Use in Patients With Nondiabetic Chronic Kidney Disease

September 20, 2021

From Bayer

Via Business Wire

Latest Analyses of Vitrakvi® (larotrectinib) Support Consistently Meaningful Clinical Profile for Both Adult and Pediatric Patients with TRK Fusion Cancer

September 16, 2021

From Bayer

Via Business Wire

NUBEQA® (darolutamide) Impact on Local Symptoms Evaluated in Men with Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)

September 14, 2021

From Bayer

Via Business Wire

Andes Raises USD 15 Million in Series A Funding Co-Led by Leaps by Bayer and Cavallo Ventures

September 14, 2021

From Bayer

Via Business Wire

Bayer Announces Recipients of the Second Annual Pulmonary Hypertension Accelerated Awards

September 10, 2021

From Bayer

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.